Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Hp02 a multicentre controlled study of inline radio-frequency ablation device for liver transection.

Hp02 a multicentre controlled study of inline radio-frequency ablation device for liver transection. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Hp02 a multicentre controlled study of inline radio-frequency ablation device for liver transection. Abstract Text:

    p yaoP Yao,f chuF Chu,m schillingM Schilling,r zuckermanR Zuckerman,j marchiJ Marchi,d l morrisD L Morris,

    Purpose Intraoperative blood loss during liver resection remains a major concern due to association with higher postoperative complications. The InLine RFA device (ILRFA) (Resect Medical Inc(R) Fremont CA) has achieved promising results in liver surgery with minimal blood loss and no increase of postoperative complications. In this multicentre controlled study, 108 patients undergoing liver resection were investigated. Methodology 108 liver resections were performed in 4 medical centres, consisting of 54 ILRFA and 54 ultrasonic Surgical Aspirator (USA) transection as the control group. Pringle manoeuvre was applied only when required. Blood loss was measured from sponge weights and suction bottle contents. Results The type of liver resection was very similar in both groups. Median number of RFA deployments was 3 (1-12) with a median coagulation time of 9 (3-36) minutes. Median operation blood loss was 165 +/- 20 ml (5-675 ml) in the ILRFA and 654 +/-83 ml (80-3600 ml) in the control, a 74.8% reduction (P < 0.001). The median transection blood loss per unit resection area was 3.29 +/- 0.40 (0.14-12.33) ml/cm2 in the ILRFA patients compared with 6.41 +/- 0.71 (0.92-36) ml/cm2 in controls, the reduction was 48.7% (P < 0.001). The transection time in ILRFA was slightly faster than that in controls, but not significantly different. Conclusion ILRFA precoagulation is a safe, effective technique for liver resections which significantly reduces blood loss.

    Hp02 a multicentre controlled study of inline radio-frequency ablation device for liver transection. Publishing Authors By Initials

    p yaoP Yao,f chuF Chu,m schillingM Schilling,r zuckermanR Zuckerman,j marchiJ Marchi,dl morrisDL Morris,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Hp02 a multicentre controlled study of inline radio-frequency ablation device for liver transection. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: ANZ journal of surgery

    VOLUME: 77 Suppl 1

    Page Numbers: A40

    Journal Abbreviation:

    ISSN: 1445-1433

    DAY: 10

    MONTH: May

    YEAR: 2007

    Hp02 a multicentre controlled study of inline radio-frequency ablation device for liver transection. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101086634

    Hp02 a multicentre controlled study of inline radio-frequency ablation device for liver transection. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Hp02 a multicentre controlled study of inline radio-frequency ablation device for liver transection. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Hp02 a multicentre controlled study of inline radio-frequency ablation device for liver transection.

    AFFILIATION: University of New South Wales, New South Wales, Australia.

    Country: Australia

    Australia Research PublicationAustralia Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: ANZ J Surg

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Hp02 a multicentre controlled study of inline radio-frequency ablation device for liver transection Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News